INTRODUCTIONAdenoviral conjunctivitis is a major cause of ocular morbidity worldwide. The severity of adenovirus eye infections ranges from mild subclinical cases to severe cases resulting in visual reduction for weeks or even months. The infection is characterized by serious conjunctival infection, severe discharge, the formation of follicles, and a pseudomembrane, lacrimation, hyperemia, papillary hypertrophy, and lymphadenopathy. Severe infections can also lead to ocular lesions that can last from months to years. Due to the structural stability of the adenoviral capsids, the virus can survive outside of hosts in surfaces for long periods, a characteristic facilitating its spread. Moreover, adenoviral epidemic kiratoconjunctivitis (EKC) is a highly contagious disease found in communal and nosocomial outbreaks, with serious social consequences for both health and economics.Most severe cases of adenoviral EKC are caused by infections of types of Human mastadenovirus D (HAdV‐D) 8, 37, 53, 54, 56, and 64. Type 64 was formerly known as type 19a and recently renamed due to its recombinant origin. Types 8, 37, and 64 have frequently been isolated in EKC outbreaks worldwide since 1954. In contrast, types 53, 54, and 56 were recently characterized as new types product of recombination events. The severity, frequency, and distribution of
Journal of Medical Virology – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera